Literature DB >> 29052155

Special Edition on Utility Measurement, PharmacoEconomics.

Andrew Lloyd1.   

Abstract

Mesh：

Year:  2017        PMID： 29052155     DOI： 10.1007/s40273-017-0542-0

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

Review 1.  International Regulations and Recommendations for Utility Data for Health Technology Assessment.

Authors:  Donna Rowen; Ismail Azzabi Zouraq; Helene Chevrou-Severac; Ben van Hout
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

2.  Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer: A Survey Capturing Experiences from a Diverse Sample of UK Patients.

Authors:  Andrew J Lloyd; Cicely Kerr; James Penton; Gerhart Knerer
Journal:  Value Health       Date:  2015-10-21       Impact factor: 5.725

3.  Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.

Authors:  Sanjeewa Kularatna; Joshua Byrnes; Yih Kai Chan; Melinda J Carrington; Simon Stewart; Paul A Scuffham
Journal:  Int J Cardiol       Date:  2016-11-09       Impact factor: 4.164

4.  Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey.

Authors:  S Acaster; S Gaugris; G Velikova; K Yong; A J Lloyd
Journal:  Support Care Cancer       Date:  2012-08-12       Impact factor: 3.603

Review 5.  A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models.

Authors:  John Brazier; Roberta Ara; Donna Rowen; Helene Chevrou-Severac
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

6.  Condition-specific preference-based measures: benefit or burden?

Authors:  Matthijs M Versteegh; Annemieke Leunis; Carin A Uyl-de Groot; Elly A Stolk
Journal:  Value Health       Date:  2012-02-09       Impact factor: 5.725
  6 in total
  1 in total

Review 1.  An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis.

Authors:  Matthew Franklin; James Lomas; Simon Walker; Tracey Young
Journal:  Pharmacoeconomics       Date:  2019-05       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.